Eton Pharmaceuticals, Inc.
(NASDAQ: ETON)

Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.

16.260

-0.550 (-3.27%)
Range 16.235 - 16.860   (3.85%)
Open 16.700
Previous Close 16.810
Bid Price 3.500
Bid Volume 22
Ask Price 4.000
Ask Volume 22
Volume 191,770
Value -
Remark
Delayed prices. Updated at 06 Dec 2025 05:00.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis